BCRX
BioCryst Pharmaceuticals Inc
Price:  
8.96 
USD
Volume:  
5,123,797.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BCRX Relative Valuation

-166.4%
Upside

As of 2025-07-01, the Relative Valuation of BioCryst Pharmaceuticals Inc (BCRX) is (5.95) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.96 USD, the upside of BioCryst Pharmaceuticals Inc based on Relative Valuation is -166.4%.

The range of the Relative Valuation is (5.75) - (6.46) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 22.5x - 25.3x 23.9x
Forward P/E multiples 17.2x - 28.2x 22.7x
Fair Price (5.75) - (6.46) (5.95)
Upside -164.2% - -172.2% -166.4%
8.96 USD
Stock Price
(5.95) USD
Fair Price

BCRX Relative Valuation - Historical P/E Data

Date P/E
2025-06-27 -36.63
2025-06-26 -37.80
2025-06-25 -38.12
2025-06-24 -38.86
2025-06-23 -38.78
2025-06-20 -39.53
2025-06-18 -38.98
2025-06-17 -39.02
2025-06-16 -40.27
2025-06-13 -40.58
2025-06-12 -40.70
2025-06-11 -41.52
2025-06-10 -43.09
2025-06-09 -43.48
2025-06-06 -43.20
2025-06-05 -42.97
2025-06-04 -43.20
2025-06-03 -43.79
2025-06-02 -41.99
2025-05-30 -42.07
2025-05-29 -42.58
2025-05-28 -41.33
2025-05-27 -42.23
2025-05-23 -41.44
2025-05-22 -40.66
2025-05-21 -39.41
2025-05-20 -40.43
2025-05-19 -40.58
2025-05-16 -40.07
2025-05-15 -39.96
2025-05-14 -38.55
2025-05-13 -39.37
2025-05-12 -40.46
2025-05-09 -39.02
2025-05-08 -38.82
2025-05-07 -39.45
2025-05-06 -40.19
2025-05-05 -43.16
2025-05-02 -34.95
2025-05-01 -34.09
2025-04-30 -34.63
2025-04-29 -33.03
2025-04-28 -32.56
2025-04-25 -32.83
2025-04-24 -32.17
2025-04-23 -31.15
2025-04-22 -30.60
2025-04-21 -29.47
2025-04-17 -28.96
2025-04-16 -28.25